Literature DB >> 29524304

Relevance and Application of Read-Across - Mini Review of European Consensus Platform for Alternatives and Scandinavian Society for Cell Toxicology 2017 Workshop Session.

Sharon Buring Stuard1, Tuula Heinonen2.   

Abstract

Structure activity relationship (SAR)-based read-across is an effective approach for addressing data gaps in human health risk assessment for 'data-poor' chemicals. In read-across, available data on chemical structural analogues are used to predict the toxicity potential of the data-poor chemical. This approach has long been recognized by regulatory agencies and used by industry to evaluate the hazards of chemicals for which there are limited direct data. Construction of a scientifically robust SAR-based read-across hazard assessment is a complex and iterative process involving multiple considerations in each step. Traditional in vivo data generated using regulatory guideline compliant study designs typically forms the basis for read-across assessments. Recently, however, new data streams have been explored and incorporated to enhance read-across predictivity. These in vitro and omics data streams may be used in different ways involving identification of hazards or to provide insight into modes of action for observed toxicological responses. These 'new approach methods' can also enable comparison of biological responses across analogues or a category of structurally related chemicals in order to establish a pattern of biological similarity in addition chemical similarity and/or to help address potency differences across a category. The purpose of this workshop session was to inform on practical considerations in conducting SAR-based read-across assessments and to review recent activities related to application of new approach methods to the practice of read-across.
© 2018 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29524304     DOI: 10.1111/bcpt.13006

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  4 in total

1.  Exploring current read-across applications and needs among selected U.S. Federal Agencies.

Authors:  Grace Patlewicz; Lucina E Lizarraga; Diego Rua; David G Allen; Amber B Daniel; Suzanne C Fitzpatrick; Natàlia Garcia-Reyero; John Gordon; Pertti Hakkinen; Angela S Howard; Agnes Karmaus; Joanna Matheson; Moiz Mumtaz; Andrea-Nicole Richarz; Patricia Ruiz; Louis Scarano; Takashi Yamada; Nicole Kleinstreuer
Journal:  Regul Toxicol Pharmacol       Date:  2019-05-10       Impact factor: 3.271

Review 2.  Recent Advances in Probabilistic Dose-Response Assessment to Inform Risk-Based Decision Making.

Authors:  Weihsueh A Chiu; Greg M Paoli
Journal:  Risk Anal       Date:  2020-09-23       Impact factor: 4.000

3.  Application of Biomarker Tools Using Bivalve Models Toward the Development of Adverse Outcome Pathways for Contaminants of Emerging Concern.

Authors:  Bushra Khan; Kay T Ho; Robert M Burgess
Journal:  Environ Toxicol Chem       Date:  2020-06-23       Impact factor: 4.218

Review 4.  Use cases, best practice and reporting standards for metabolomics in regulatory toxicology.

Authors:  Mark R Viant; Timothy M D Ebbels; Richard D Beger; Drew R Ekman; David J T Epps; Hennicke Kamp; Pim E G Leonards; George D Loizou; James I MacRae; Bennard van Ravenzwaay; Philippe Rocca-Serra; Reza M Salek; Tilmann Walk; Ralf J M Weber
Journal:  Nat Commun       Date:  2019-07-10       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.